ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405,661 | +7.6% | 14,947 | +42.9% | 0.00% | – |
| Q1 2023 | $376,945 | -92.6% | 10,462 | -91.9% | 0.00% | -100.0% |
| Q4 2022 | $5,083,050 | -14.2% | 128,619 | -12.7% | 0.01% | -25.0% |
| Q3 2022 | $5,921,000 | -54.9% | 147,370 | -52.8% | 0.01% | -50.0% |
| Q2 2022 | $13,121,000 | +8.7% | 312,118 | +0.7% | 0.02% | +33.3% |
| Q1 2022 | $12,073,000 | -38.5% | 309,882 | -37.1% | 0.01% | -36.8% |
| Q4 2021 | $19,638,000 | +19.5% | 492,794 | +8.3% | 0.02% | +5.6% |
| Q3 2021 | $16,440,000 | -17.6% | 454,894 | -6.6% | 0.02% | -18.2% |
| Q2 2021 | $19,963,000 | -15.2% | 487,022 | -9.8% | 0.02% | -24.1% |
| Q1 2021 | $23,551,000 | -22.5% | 539,906 | -11.1% | 0.03% | -27.5% |
| Q4 2020 | $30,386,000 | – | 607,115 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |